<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="The study’s purpose was to assess beta-blockers efficacy in preventing" exact="migraine" post="and tension-type headache. Methods Cochrane Register of Controlled Trials;"/>
 <result pre="least one comparison was a beta-blocker for the prevention of" exact="migraine" post="or tension-type headache in adults. The primary outcome, headache"/>
 <result pre="58 comparative effectiveness trials. Compared to placebo, propranolol reduced episodic" exact="migraine" post="headaches by 1.5 headaches/month at 8 weeks (95% CI:"/>
 <result pre="quality evidence that propranolol is better than placebo for episodic" exact="migraine" post="headache. Other comparisons were underpowered, rated as low-quality based"/>
 <result pre="impossible. There were few trials examining beta-blocker effectiveness for chronic" exact="migraine" post="or tension-type headache though there was limited evidence of"/>
 <result pre="problem, world-wide. The two most common types of headaches are" exact="migraine" post="and tension-type. Migraines have a prevalence of 6–8% ["/>
 <result pre="year [ 15; 16] in the US alone. While episodic" exact="migraine" post="is more common than chronic migraine, chronic migraine has"/>
 <result pre="While episodic migraine is more common than chronic migraine, chronic" exact="migraine" post="has greater disability as well as financial and occupational"/>
 <result pre="to assess the efficacy of beta-blockers in the prophylaxis of" exact="migraine" post="and tension-type headache. Two previous systematic reviews focused on"/>
 <result pre="previous systematic reviews focused on the use of beta-blockers in" exact="migraine" post="headaches, both are more than 15 years old ["/>
 <result pre="management that included beta-blockers. Shamliyan reviewed pharmacologic treatment for episodic" exact="migraine" post="and reported that beta-blockers were effective; their outcome was"/>
 <result pre="the other meta-analysis, we found that beta-blockers were beneficial for" exact="migraine" post="headaches, but did not differentiate between episodic and chronic"/>
 <result pre="migraine headaches, but did not differentiate between episodic and chronic" exact="migraine" post="headaches, did not include all possible outcomes and did"/>
 <result pre="to determine if the headache could be reasonably classified as" exact="migraine" post="or tension-type headache and as either frequent episodic or"/>
 <result pre="based on results from our previous review of treatment of" exact="migraine" post="headaches [ 17]. Studies with more than one arm"/>
 <result pre="effectiveness arms. Nearly all trials (n = 106) focused on" exact="migraine" post="headaches, most (n = 83) could be classified as"/>
 <result pre="secondary outcomes, the majority of trials studied subjects with episodic" exact="migraine" post="headaches ( Table 3). Propranolol was the most commonly"/>
 <result pre="— Low 10 weeks -0.70 (-4.0 to 2.6) — Chronic" exact="migraine" post="There were four trials that evaluated beta-blockers for chronic"/>
 <result pre="migraine There were four trials that evaluated beta-blockers for chronic" exact="migraine" post="headaches, none were placebo controlled. ( Table 6). Propranolol"/>
 <result pre="trials. Nearly all evaluated the efficacy of beta-blockers for episodic" exact="migraine" post="headaches. Compared to placebo, propranolol was effective in reducing"/>
 <result pre="headaches. Compared to placebo, propranolol was effective in reducing episodic" exact="migraine" post="frequency. The effect began as early as four weeks."/>
 <result pre="benefit. Acebutolol, alprenolol and nadolol appeared to be ineffective in" exact="migraine" post="prophylaxis. This is unlikely to be due to properties"/>
 <result pre="in the United States, is well-established as effective in treating" exact="migraine" post="headache. Universally, beta-blockers were associated with bradycardia and with"/>
 <result pre="have been studied almost exclusively in the management of episodic" exact="migraine" post="headaches. Their benefit for chronic episodic or tension-type headaches"/>
 <result pre="is effective in reducing the burden of patients with episodic" exact="migraine" post="headaches, reducing headaches from 5 to 3 headaches a"/>
 <result pre="from 5 to 3 headaches a month. This means that" exact="migraine" post="sufferers given propranolol will have substantial residual headache burden."/>
 <result pre="774– 777. 10.1177/033310240102100708 11595011 2 Wang SJ . Epidemiology of" exact="migraine" post="and other types of headache in Asia. Current Neurology"/>
 <result pre=", Neuhauser H . Prevalence and burden of headache and" exact="migraine" post="in Germany. Headache 2009; 49( 1): 79– 89. 10.1111/j.1526-4610.2008.01263.x"/>
 <result pre="D , Reed ML , Turkel CC et al. Chronic" exact="migraine" post="prevalence, disability, and sociodemographic factors: results from the American"/>
 <result pre="of life, disability and severity of disease in patients with" exact="migraine" post="attending to a specialty headache center . Headache 2010;"/>
 <result pre="cycle of migraine: patients' quality of life during and between" exact="migraine" post="attacks. Clin Ther 2007; 29( 5): 939– 949. 10.1016/j.clinthera.2007.05.008"/>
 <result pre="RB , Stewart WF , Berger ML . Burden of" exact="migraine" post="in the United States: disability and economic costs. Archives"/>
 <result pre="813– 818. 10219926 16 Goldberg LD . The cost of" exact="migraine" post="and its treatment. Am J Manag Care 2005; 11("/>
 <result pre="Jorgensen T , Jensen R . Has the prevalence of" exact="migraine" post="and tension-type headache changed over a 12-year period? European"/>
 <result pre="R , Gulliford M , Ridsdale L . Headache and" exact="migraine" post="in primary care: consultation, prescription, and referral rates in"/>
 <result pre="26 Chronicle E , Mulleners W . Anticonvulsant drugs for" exact="migraine" post="prophylaxis. Cochrane Library 2004;( 3). 27 Linde K ,"/>
 <result pre="3). 27 Linde K , Rossnagel K . Propranolol for" exact="migraine" post="prophylaxis. Cochrane Database Syst Rev 2004;( 2): CD003225 10.1002/14651858.CD003225.pub2"/>
 <result pre="Hayashino Y . Botulinum toxin A for prophylactic treatment of" exact="migraine" post="and tension headaches in adults: a meta-analysis . JAMA"/>
 <result pre="T , Davenport WJ , Becker WJ . Prophylaxis of" exact="migraine" post="headache. CMAJ 2010; 182( 7): E269– E276. 10.1503/cmaj.081657 20159899"/>
 <result pre="Canepari C . Selective serotonin re-uptake inhibitors (SSRIs) for preventing" exact="migraine" post="and tension-type headaches . Cochrane Database Syst Rev 2005;("/>
 <result pre="Ashman E . Evidence-based guideline update: pharmacologic treatment for episodic" exact="migraine" post="prevention in adults: report of the Quality Standards Subcommittee"/>
 <result pre=", Dodick D . Persistence and switching patterns of oral" exact="migraine" post="prophylactic medications among patients with chronic migraine: a retrospective"/>
 <result pre="1830566 40 Linde K , Rossnagel K . Propranolol for" exact="migraine" post="prophylaxis. Cochrane Database Syst Rev 2004;( 2): CD003225 10.1002/14651858.CD003225.pub2"/>
 <result pre=", Taylor FR et al. Preventive pharmacologic treatments for episodic" exact="migraine" post="in adults. J Gen Intern Med 2013; 28( 9):"/>
 <result pre="propranolol LA 80 mg and propranolol LA 160 mg in" exact="migraine" post="prophylaxis: a placebo controlled study . Cephalalgia 1993; 13("/>
 <result pre="Petersen EN . Propranolol and femoxetine, a HT-uptake inhibitor, in" exact="migraine" post="prophylaxis. A double-blind crossover study . Acta Neurol Scand"/>
 <result pre="Kristensen TN et al. Prophylactic treatment of classical and non-classical" exact="migraine" post="with metoprolol—a comparison with placebo . Cephalalgia 1983; 3("/>
 <result pre="A double-blind, randomized trial of low-dose topiramate vs propranolol in" exact="migraine" post="prophylaxis . 2008; 118( 5): 301– 305. 64 Baldrati"/>
 <result pre=", Baruzzi A et al. Propranolol and acetylsalicylic acid in" exact="migraine" post="prophylaxis. Double-blind crossover study . Acta Neurol Scand 1983;"/>
 <result pre="Amato D , Scellini T et al. Long-term outcome of" exact="migraine" post="therapy: predictive value of the frontotemporal nitroglycerin test ."/>
 <result pre="JG . Propranolol vs flunarizine vs flunarizine plus propranolol in" exact="migraine" post="without aura prophylaxis. A double-blind trial . Arq Neuropsiquiatr"/>
 <result pre=", Nielsen JL , Moller CE . Prophylactic treatment of" exact="migraine" post="with propranolol. A clinical trial. Acta Neurol Scand 1974;"/>
 <result pre="4611129 69 Briggs RS , Millac PA . Timolol in" exact="migraine" post="prophylaxis. Headache 1979; 19: 379– 381. 511540 70 Carroll"/>
 <result pre="HP , Nappi G et al. Efficacy and tolerability in" exact="migraine" post="prophylaxis of flunarizine in reduced doses: a comparison with"/>
 <result pre=", Sandrini G , Wang SJ et al. Topiramate in" exact="migraine" post="prophylaxis—results from a placebo-controlled trial with propranolol as an"/>
 <result pre="combination of propranolol and nortriptyline for the preventive treatment of" exact="migraine" post=". 2009; 67( 4): 973– 977. 77 Ekbom K"/>
 <result pre="of LB-46 (d, 1-4-(2-hydroxy-3-isopropylaminopropoxy)indol. An adrenergic beta-receptor blocking agent in" exact="migraine" post="prophylaxis . Headache 1972; 12( 1): 15– 17. 4402287"/>
 <result pre="1): 15– 17. 4402287 78 Ekbom K . Alprenolol for" exact="migraine" post="prophylaxis. Headache 1975; 15( 2): 129– 132. 1097368 79"/>
 <result pre="B , Henriksson KG , Johannsson V . Propranolol for" exact="migraine" post="prophylaxis. Headache 1976; 16: 238– 245. 977330 82 Forssman"/>
 <result pre="B , Lindblad CJ , Zbornikova V . Atenolol for" exact="migraine" post="prophylaxis. Headache 1983; 23( 4): 188– 190. 6350226 83"/>
 <result pre="and safety of flunarizine to propranolol in the prophylaxis of" exact="migraine" post=". Can J Neurol Sci 1992; 19( 3): 340–"/>
 <result pre="Responders and non-responders to metoprolol, propranolol and nifedipine treatment in" exact="migraine" post="prophylaxis: a dose-range study based on time-series analysis ."/>
 <result pre="Jivad N . The prophylactic activity of propranol and nimodipineon" exact="migraine" post="headache. 2013; 8( 2): 144– 146. 88 Grotemeyer KH"/>
 <result pre=", Schlake HP , Husstedt IW . [ Prevention of" exact="migraine" post="with metoprolol and flunarizine. A double-blind crossover study]. Nervenarzt"/>
 <result pre="HP , Husstedt IW . Acetylsalicylic acid vs. metoprolol in" exact="migraine" post="prophylaxis—a double-blind cross-over study . Headache 1990; 30( 10):"/>
 <result pre="beta 1-selective beta-blockers in their effect on platelet function in" exact="migraine" post="patients . Acta Neurol Scand 1986; 74( 6): 475–"/>
 <result pre="Mogelvang B , Simonsen H . Acupuncture versus metoprolol in" exact="migraine" post="prophylaxis: a randomized trial of trigger point inactivation ."/>
 <result pre="et al. Effect of preventive (Î 2 blocker) treatment, behavioural" exact="migraine" post="management, or their combination on outcomes of optimised acute"/>
 <result pre=", Hellman P , Akesson JA et al. Atenolol in" exact="migraine" post="prophylaxis a double-blind cross-over multicentre study. Headache 1987; 27("/>
 <result pre=". Comparison of mefenamic acid and propranolol with placebo in" exact="migraine" post="prophylaxis. Acta Neurol Scand 1986; 73( 5): 490– 492."/>
 <result pre="new 5-HT uptake inhibitor—and propranolol in the prophylactic treatment of" exact="migraine" post=". Acta neurologica Scandinavica 1983; 68: 262– 267. 6606930"/>
 <result pre="of divalproex with propranolol and placebo for the prophylaxis of" exact="migraine" post="without aura . Arch Neurol 1997; 54( 9): 1141–"/>
 <result pre="and systematic relaxation versus propranolol in long term prophylaxis of" exact="migraine" post=". Complement Ther Med 2005; 13( 3): 165– 174."/>
 <result pre="of divalproex sodium and propranolol HCl in the prevention of" exact="migraine" post="headaches . HEADACHE Q 1994; 5: 50– 53. 106"/>
 <result pre="107 Kuritzky A , Hering R . Prophylactic treatment of" exact="migraine" post="with long acting propranolol—a comparison with placebo . Cephalalgia"/>
 <result pre="Mayer K , Schroth G . Clomipramine and metoprolol in" exact="migraine" post="prophylaxis—a double-blind crossover study. Headache 1985; 25( 2): 107–"/>
 <result pre="effect of 5-hydroxytryptophan and propranolol in the interval treatment of" exact="migraine" post="]. Schweiz Med Wochenschr 1991; 121( 43): 1585– 1590."/>
 <result pre="4): 163– 167. 4566216 114 Mathew NT . Prophylaxis of" exact="migraine" post="and mixed headache. A randomized controlled study. Headache 1981;"/>
 <result pre=", Pedersen KK , Christiansen LV . Prophylactic treatment of" exact="migraine" post="with tolfenamic acid, propranolol and placebo. Acta Neurol Scand"/>
 <result pre=", Srinivasa R . Oral riboflavin versus oral propranolol in" exact="migraine" post="prophylaxis: An open label randomized controlled trial . 2011;"/>
 <result pre="Melville ID . A double blind trial of acebutolol for" exact="migraine" post="prophylaxis. Headache 1978; 18( 1): 20– 22. 348644 119"/>
 <result pre="Gustavsson CL , Furberg B . Nadolol and propranolol in" exact="migraine" post="management. Headache 1986; 26( 10): 490– 493. 3546194 120"/>
 <result pre="G , Johansson F et al. Metoprolol and propranolol in" exact="migraine" post="prophylaxis: a double-blind multicentre study. Acta Neurol Scand 1984;"/>
 <result pre="Feve J , Masson M et al. Long-acting propranolol in" exact="migraine" post="prophylaxis: results of a double-blind, placebo-controlled study . Cephalalgia"/>
 <result pre="propranolol hydrochloride and a placebo control for the prophylaxis of" exact="migraine" post="headache . Headache 1985; 25( 6): 320– 324. 3902723"/>
 <result pre="Randomized, placebo-controlled trial of propranolol added to topiramate in chronic" exact="migraine" post=". Neurology 2012; 78( 13): 976– 984. 10.1212/WNL.0b013e31824d5846 22377815"/>
 <result pre="H , Alslev T et al. Flunarizine versus metoprolol in" exact="migraine" post="prophylaxis: a double-blind, randomized parallel group study of efficacy"/>
 <result pre="timolol versus propranolol and placebo in common migraine: beta-blockers in" exact="migraine" post=". Cephalalgia 1982; 2( 3): 165– 170. 10.1046/j.1468-2982.1982.0203165.x 6758949"/>
 <result pre="of phopranolol in racemic form (Inderal), D-propranolol and placebo in" exact="migraine" post=". Acta Neurol Scand 1976; 53( 3): 229– 232."/>
 <result pre="et al. A comparative study of candesartan versus propranolol for" exact="migraine" post="prophylaxis: A randomised, triple-blind, placebo-controlled, double cross-over study ."/>
 <result pre="al. Effectiveness and tolerability of acupuncture compared with metoprolol in" exact="migraine" post="prophylaxis . Headache 2006; 46( 10): 1492– 1502. 10.1111/j.1526-4610.2006.00598.x"/>
 <result pre="Olesen J . Timolol vs propranolol vs placebo in common" exact="migraine" post="prophylaxis: a double-blind multicenter trial. Acta Neurol Scand 1984;"/>
 <result pre=", Franke CL , Koehler PJ . Prophylactic treatment of" exact="migraine" post="with bisoprolol: a placebo-controlled study. Cephalalgia 1997; 17( 5):"/>
 <result pre="144 Weber RB , Reinmuth OM . The treatment of" exact="migraine" post="with propranolol. Neurology 1971; 21: 404– 405. 145 Wideroe"/>
 <result pre=", Grotemeyer KH , Scharafinski HW . [ Prevention of" exact="migraine" post="using bisoprolol. Results of a double-blind study versus metoprolol]."/>
 <result pre="148 Chen J . Clinical study of topiramate in preventing" exact="migraine" post="attacks. Sichuan Medical Journal 2009; 30( 1): 119. 149"/>
 <result pre=". Therapeutic effect of metoprolol tartrate combined with flunarizine on" exact="migraine" post="in the treatment of migraine . Journ of Integrative"/>
 <result pre="tartrate combined with flunarizine on migraine in the treatment of" exact="migraine" post=". Journ of Integrative Medicine, Cardiovascular and Cerebrovascular Diseases"/>
 <result pre="S . Therapeutic effect of sodium valproate on prevention of" exact="migraine" post="recurrence. Sichuan Medical Journal 2004; 25( 4): 416. 154"/>
 <result pre=". Therapeutic effect of metoprolol tartrate combined with flunarizine on" exact="migraine" post="in the treatment of migraine . Modern Practical Medicine"/>
 <result pre="tartrate combined with flunarizine on migraine in the treatment of" exact="migraine" post=". Modern Practical Medicine 2011; 23( 11): 1275– 1276."/>
 <result pre=". The effect of metoprolol combined with fluoxetine on preventing" exact="migraine" post="and its effect on serotonin . Chinese Journal of"/>
 <result pre="Preliminary randomized controlled trial of topiramate and propranolol to prevent" exact="migraine" post="attacks . Huaxi Pharmaceutical Journal 2005; 20( 2): 182–"/>
 <result pre="Clinical trial of a beta-receptor blocking agent (LB 46) in" exact="migraine" post="prophylaxis. Acta Neurol Scand 1972; 48( 1): 124– 128."/>
</results>
